Strategic and innovative leader with benchmark track record both in Pharmaceuticals as MedTech in EMEA
Overview
28
28
years of professional experience
Work History
Managing Director UK & Ireland
Johnson&Johnson
London
01.2019 - Current
Turnaround UK&Ire cluster : from years of MS & sales decline to unprecedented MS growth (+4.5 pts Medtech ’23 vs ’19) while transforming to a nextgen commercial organization moving the cluster from $500MM to $750MM.
Talent Development : 22 talents exported to top roles in Global & EMEA
Diverse & inclusive high performance culture installed.
Awards : ‘UK’s Healthiest company’, ‘Glassdoor N1 Healthcare Company ‘24’, ‘Top EthnicityEmployer’ and ‘Healthcare CEO of the Year’
Exceed’ JnJ Performance score in ’21, ’22 and ‘23
Vice President Strategy EMEA
Johnson & Johnson
Brussels
01.2016 - 12.2018
EMEA region lead for Product Launches, Strategic Pricing, HEMA, BI, Internal Training, Professional Education, Value Added Services, Commercial Excellence, Strategic Account Management, International Accounts, PMO office and Working Capital Management